Investing

Acceleration of RAD204 Phase 1 dose escalation trial

by admin
Acceleration of RAD204 Phase 1 dose escalation trial

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

What Comes After ETFs? The Case for Tokenized...

May 30, 2025

6 US Biofuel Stocks in 2025

March 7, 2025

RUA GOLD Announces C$5 Million Brokered Offering of...

February 13, 2025

Appointment of CEO and Director

April 10, 2025

Copper and Consequences: US Tariffs Stir Uncertainty in...

April 15, 2025

Lantheus increases shareholding in RAD with A$8m placement

January 10, 2025

Issue of Shares and Cleansing Notice

June 27, 2025

Crypto Market Recap: Bitcoin Stages a Comeback as...

April 11, 2025

Brunswick Exploration Announces 2025 Exploration Plans for Greenland...

February 24, 2025

Progress Update on Hydrogen Supply Chain and Prototype...

December 25, 2024